Evidence map›Paper›PMID 32631181›Full record

ArticleThe Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics2020

An Effective Intervention: Limiting Opioid Prescribing as a Means of Reducing Opioid Analgesic Misuse, and Overdose Deaths.

Brandi C Fink, Olivier Uyttebrouck, Richard S Larson

Open access · greenAbstract read
In one paragraph

Article in The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Opioid prescribing requirements to minimize unused medications after an emergency department visit for acute pain: a prospective cohort study.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2024
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Brandi C FinkBrandi Fink, Ph.D., is a licensed clinical psychologist and Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of New Mexico Health Sciences. Dr. Fink's research focuses on identifying novel neurophysiological intervention targets to improve outcomes for patients with a variety of substance use related problems. Her clinical work focuses on the treatment of substance use disorders. Olivier Uyttebrouck is a Senior Scientific Writer for the University of New Mexico Health Sciences. Richard Larson, M.D., Ph.D., is the Executive Vice Chancellor, Vice Chancellor for Research, and Professor of Pathology at the University of New Mexico Health Sciences. As an established scholar and leader, Dr. Larson oversees an array of activities and programs at a $2.2 billion academic health center. These activities have spanned operational, clinical, educational and research missions.
Olivier UyttebrouckBrandi Fink, Ph.D., is a licensed clinical psychologist and Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of New Mexico Health Sciences. Dr. Fink's research focuses on identifying novel neurophysiological intervention targets to improve outcomes for patients with a variety of substance use related problems. Her clinical work focuses on the treatment of substance use disorders. Olivier Uyttebrouck is a Senior Scientific Writer for the University of New Mexico Health Sciences. Richard Larson, M.D., Ph.D., is the Executive Vice Chancellor, Vice Chancellor for Research, and Professor of Pathology at the University of New Mexico Health Sciences. As an established scholar and leader, Dr. Larson oversees an array of activities and programs at a $2.2 billion academic health center. These activities have spanned operational, clinical, educational and research missions.
Richard S LarsonBrandi Fink, Ph.D., is a licensed clinical psychologist and Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of New Mexico Health Sciences. Dr. Fink's research focuses on identifying novel neurophysiological intervention targets to improve outcomes for patients with a variety of substance use related problems. Her clinical work focuses on the treatment of substance use disorders. Olivier Uyttebrouck is a Senior Scientific Writer for the University of New Mexico Health Sciences. Richard Larson, M.D., Ph.D., is the Executive Vice Chancellor, Vice Chancellor for Research, and Professor of Pathology at the University of New Mexico Health Sciences. As an established scholar and leader, Dr. Larson oversees an array of activities and programs at a $2.2 billion academic health center. These activities have spanned operational, clinical, educational and research missions.
Micro Focus (United States) · US

Funding

UNM HSC Clinical and Translational Science CenterUL1TR001449 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CAMPEN, MATTHEW J, PANDHI, NANCY · 2015 to 2024
$36.9M
NCATS NIH HHS UL1 TR001449
6 · The paper itself

Abstract

Overdose deaths involving prescription opioids killed more than 17,000 Americans in 2017, marking a five-fold increase since 1999. High prescribing rates of opioid analgesics have been a substantial contributor to prescription opioid misuse, dependence, overdose and heroin use. There was recognition approximately ten years ago that opioid prescribing patterns were contributing to this startling increase in negative opioid-related outcomes, and federal actions, including Medicare reimbursement reform and regulatory actions, were initiated to restrict opioid prescribing. The current manuscript is a description of those actions, the effect of those actions on opioid prescribing and related patient outcomes. We also describe our proposal of methods of expanding these efforts as an important piece to further reduce opioid-related misuse, dependence, and overdose death.

Indexed as

Analgesics, OpioidFederal GovernmentGovernment RegulationHumansOpiate OverdosePractice Patterns, Physicians'Prescription Drug MisuseState GovernmentUnited StatesAnalgesics, Opioid

Identifiers

PMID32631181
PMCPMC10860647
OpenAlexW3040315763

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.